https://conmedru-nuclear-web-199d.twc1.net 2026-04-03T23:38:13.760Z daily 1 https://conmedru-nuclear-web-199d.twc1.net/news 2026-04-03T23:38:13.760Z monthly 0.9 https://conmedru-nuclear-web-199d.twc1.net/about 2026-04-03T23:38:13.760Z monthly 0.5 https://conmedru-nuclear-web-199d.twc1.net/contact 2026-04-03T23:38:13.760Z monthly 0.5 https://conmedru-nuclear-web-199d.twc1.net/category/vizualizaciya 2026-04-03T23:38:13.760Z daily 0.7 https://conmedru-nuclear-web-199d.twc1.net/category/teranostika 2026-04-03T23:38:13.760Z daily 0.7 https://conmedru-nuclear-web-199d.twc1.net/category/radioterapiya 2026-04-03T23:38:13.760Z daily 0.7 https://conmedru-nuclear-web-199d.twc1.net/category/radiofarmpreparaty 2026-04-03T23:38:13.760Z daily 0.7 https://conmedru-nuclear-web-199d.twc1.net/category/klinika 2026-04-03T23:38:13.760Z daily 0.7 https://conmedru-nuclear-web-199d.twc1.net/category/industriya 2026-04-03T23:38:13.760Z daily 0.7 https://conmedru-nuclear-web-199d.twc1.net/news/targeted-beta-particle-plus-conversion-and-auger-electron-therapy-with-161tb-labeled-somatostatin-receptor-antagonist-dota-lm3-a-phase-0-study 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/influence-of-subcellular-localization-on-the-cytotoxicity-of-targeted-alpha-therapy 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/autopet-challenge-on-fully-automated-lesion-segmentation-in-oncologic-petct-imaging-part-2-domain-generalization 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/monitoring-of-disease-in-patients-receiving-177lu-psma-617-therapy-in-routine-practice 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/concepts-in-phase-1-radiopharmaceutical-therapy-trial-designs-lessons-from-the-snmmi-dose-optimization-in-radiopharmaceutical-therapy-development-workshop 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/assessment-of-response-to-regorafenib-in-patients-with-glioma-relapse-using-18f-fet-pet-and-mri 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/a-timeline-of-multimodality-imaging 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/cd70-targeted-immuno-petct-for-detecting-heterogeneous-cd70-expression-in-lymphomas-a-pilot-clinical-study 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/radionuclide-selection-influences-imaging-outcomes-in-immuno-pet-with-a-brain-penetrating-anti-amyloid-beta-antibody 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/nuclear-medicine-ai-in-action-the-bethesda-report-ai-summit-2024 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/macrophage-targeted-11c-dpa-713-petct-imaging-for-early-therapeutic-evaluation-of-anti-tumor-necrosis-factor-treatment-in-rheumatoid-arthritis 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/nuclear-medicine-and-external-beam-radiation-therapy-in-prostate-cancer-a-synergistic-approach 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/first-in-human-study-of-the-carbohydrate-nanoparticle-64cu-macrin 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/chronic-hematologic-toxicity-after-peptide-receptor-radionuclide-therapy-an-underrecognized-challenge-in-neuroendocrine-tumors 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/quantitative-comparison-of-spect-and-pet-performance-for-clinical-theranostic-applications 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/bantam-01-a-multicenter-open-label-first-in-human-phase-1-dose-escalation-and-expansion-study-of-225ac-gpc3-bay-3547926-in-patients-with-advanced-hepatocellular-carcinoma 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/tetraspanin-8-as-a-tumor-selective-immuno-pet-target-in-hepatocellular-carcinoma 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/actinium-225-psma-versus-lutetium-177-psma-radioligand-therapy-for-metastatic-castration-resistant-prostate-cancer-results-of-an-observational-study 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/biologically-individualized-radiotherapy-based-on-pet-a-novel-approach-to-treatment-optimization-of-head-and-neck-cancer 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/beyond-the-prostate-incidental-detection-of-male-breast-carcinoma-on-18f-dcfpyl 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/preclinical-evaluation-of-64cu-lnth-1363s-to-detect-cardiac-fap-positive-fibroblasts-using-pet-imaging 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/translocator-protein-18-kda-targeted-total-body-pet-imaging-reveals-immune-specific-vascular-inflammation-in-large-vessel-vasculitis-a-prospective-head-to-head-comparison-with-18f-fdg 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/summary-of-the-2024-update-of-the-north-american-guidelines-for-pediatric-administered-radiopharmaceutical-activities 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/construction-and-evaluation-of-guanylyl-cyclase-c-specific-antibody-for-noninvasive-diagnosis-and-targeted-therapy-of-colorectal-cancer 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/erratum 2026-03-28T20:04:41.729Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/fractionation-gives-therapeutic-benefit-in-animal-model-of-177lu-lu-psma-617-therapy-of-prostate-cancer 2026-03-28T12:14:47.972Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/interpreting-clonal-hematopoiesis-following-177lu-lu-psma-617-clinical-risk-versus-genomic-signal 2026-03-28T12:14:33.326Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/inter-center-variability-of-dosimetry-methodology-and-the-impact-on-reported-absorbed-dose-for-177lu-lu-psma-617-therapy 2026-03-28T12:14:21.174Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/increased-uptake-of-68ga-dota-iba-in-polymorphous-adenocarcinoma-of-the-parotid-gland 2026-03-28T12:13:58.960Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/restoring-radioiodine-avidity-in-radioiodine-refractory-differentiated-thyroid-cancer-with-genotype-guided-mapk-inhibition-and-dosimetry-guided-radioiodine 2026-03-28T12:13:31.316Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/18f-fdg-petct-in-disseminated-cryptococcosis-mimicking-malignancy-with-rib-osteolysis-and-chest-wall-invasion 2026-03-28T12:12:46.448Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/nectin-4-targeted-radiotheranostics-for-personalized-cancer-therapy-a-systematic-review 2026-03-28T09:33:02.785Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/leading-through-change-reflections-from-jason-lewis 2026-03-28T08:03:01.285Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/molecular-mechanisms-of-antitumor-effect-in-targeted-alpha-radionuclide-therapy 2026-03-24T04:03:31.069Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/clinical-application-of-targeted-alpha-therapy-using-astatine 2026-03-23T17:33:21.076Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/preclinical-evaluation-of-177lu-lu-art-101-for-radiopharmaceutical-therapy-of-advanced-prostate-cancer 2026-03-23T16:03:19.534Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/radiopharmaceutical-an-update-and-comparison-of-preclinical-investigation-result-of-alpha-and-beta-emitter-radioisotope 2026-03-23T13:03:16.524Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/dosimetric-analysis-reveals-rapid-clearance-and-low-absorbed-dose-of-177lu-lu-psma-617-in-non-prostate-cancers-with-high-psma-expression 2026-03-23T11:33:15.086Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/a-phase-ii-study-evaluating-pharmacokinetics-and-dosimetry-of-177lu-psma-617-radioligand-therapy-in-chinese-participants-with-progressive-metastatic-castration-resistant-prostate-cancer 2026-03-23T10:52:19.049Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/predicting-overall-survival-in-pancreatic-ductal-adenocarcinoma-using-f-fdg-petct-radiomics-a-two-center-study 2026-03-23T10:03:13.821Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/relationship-between-absorbed-dose-and-suv-derived-from-spectct-imaging-and-dose-response-in-patients-with-neuroendocrine-tumors-treated-with-177lu-lu-dota-tate 2026-03-23T08:33:12.418Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/predictive-value-of-interim-11c-choline-petct-for-response-to-radium-223-in-metastatic-castration-resistant-prostate-cancer 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/researchers-introduce-genome-based-imaging-for-medical-diagnostics 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/exemplifying-excellence-in-brain-cancer-research-a-conversation-with-tim-cloughesy-david-a-nathanson-and-johannes-czernin 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/different-appearances-of-esophageal-squamous-cell-carcinoma-in-18-f-psma-petct-versus-18-f-fdg-petct 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/keeping-a-human-in-the-loop-managing-the-ethics-of-ai-in-medicine 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/preclinical-evaluation-of-225ac-ac-sibrotuzumab-employing-a-peg4-macropa-site-specific-chelation-strategy-for-targeted-ablation-of-cancer-associated-fibroblasts-in-desmoplastic-tumors 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/new-procedure-standardpractice-guidelines-for-fes-pet-imaging-of-breast-cancer 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/efficacy-of-177lu-fap-2286-and-225ac-fap-2286-in-treating-pancreatic-adenocarcinoma-with-lymph-node-metastasis 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/radiation-induced-side-effects-to-the-skin-due-to-177lu-psma-extravasation 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/remarkable-response-to-177lu-psma-and-177lu-dota-iba-cocktail-therapy-in-a-patient-with-dual-primary-malignancies 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/ejnmmi-research-a-vision-for-the-next-era-of-nuclear-medicine 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/comparison-between-ga-ga-fapi-46-and-f-fdg-petct-uptake-in-luminal-like-vs-her2-positive-breast-cancer 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/a-study-of-225ac-production-cross-section-by-proton-deuteron-and-neutron-irradiation-on-232th-targets-based-on-fluka-and-phits-toolkit 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/toward-rapid-actinium-225-purification-via-membrane-adsorbers-with-covalently-tethered-diglycolamide-ligands 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/mesothelin-targeted-alpha-therapy-in-pdac-with-225ac-ac-macropa-peg6-amatuximab 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/seven-year-follow-up-of-cerebellar-type-1-metabotropic-glutamate-receptor-availability-in-a-family-with-spinocerebellar-ataxia-type-1921 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/outcome-and-safety-of-single-dose-docetaxel-augmented-targeted-radionuclide-therapy-using-177lu-lu-psma-617-radioligand-therapy-in-treatment-refractory-mcrpc-preliminary-evidence-from-a-pilot-experience 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/increased-99mtc-maa-uptake-in-supraclavicular-brown-adipose-tissue-in-a-pediatric-patient-with-hereditary-hemorrhagic-telangiectasia 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/18f-dopa-pet-silence-in-high-grade-glioma-subtype-f 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/small-doses-of-mushrooms-can-have-a-beneficial-effect-on-mental-disorders-study-finds 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/comparable-diagnostic-performance-of-68ga-fapi-and-18f-fdg-petct-in-perineal-rhabdomyosarcoma 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/reversible-parkinsonism-with-recovery-of-123i-ioflupane-dat-spect-after-treating-rheumatoid-meningitis 2026-03-20T04:01:59.043Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/psma-petct-derived-indicators-and-outcomes-after-177lu-lu-psma-617-a-multicenter-retrospective-analysis-from-the-us-expanded-access-program 2026-03-19T17:31:48.645Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/phase-2-prospective-trial-of-retreatment-with-177lu-lu-psma-617-molecular-radiotherapy-for-metastatic-castration-resistant-prostate-cancer-re-lupsma 2026-03-19T16:01:47.162Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/angiogenesis-petmri-predicts-initial-growth-of-sporadic-vestibular-schwannomas-a-prospective-study-with-follow-up-in-29-patients-using-ga-ga-nodaga-e-c-rgdyk 2026-03-19T14:31:45.578Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/a-ga-gd-labeled-petmr-imaging-probe-for-ph-assessment 2026-03-19T13:01:44.154Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/18f-fluorocholine-petct-in-a-15-year-old-patient-suggested-hpt-jt-syndrome-with-active-cemento-ossifying-fibroma 2026-03-19T11:31:42.772Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/prediction-of-tumour-hypoxia-status-from-the-washout-of-positron-emitters-in-beam-monitoring-pet-carbon-ion-irradiation-to-tumour-rat-models 2026-03-19T10:01:41.276Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/eanm-office-in-brussels-nov-2025 2026-03-19T08:39:18.463Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/novel-psma-targeting-alpha-emitting-radioligand-at-psat-3-ga-inhibits-tumor-growth-and-increases-survival-in-a-preclinical-model-of-human-xenograft-prostate-cancer 2026-03-19T08:31:40.025Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/eu-cardiovascular-health-plan-released-dec-2025 2026-03-14T04:04:44.689Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/ken-herrmann-to-be-next-editor-in-chief-of-the-journal-of-nuclear-medicine 2026-03-14T04:04:44.689Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/molecular-imaging-leadership-styles 2026-03-14T04:04:44.689Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/political-agreement-on-eu-pharmaceutical-legislation-dec-2025 2026-03-14T04:04:44.689Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/snmmi-eanm-artnet-launch-unified-pet-accreditation-dec-2025 2026-03-14T04:04:44.689Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/bounce-effect-or-local-recurrence-after-low-dose-rate-brachytherapy-of-the-prostate-when-prostate-specific-membrane-antigen-positron-emission-tomography-computed-tomography-is-false-positive-a-case-report 2026-03-14T04:04:44.689Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/launch-of-the-eanm-young-scientist-network-award 2026-03-14T04:04:44.689Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/dr-knuuti-at-icnc2026-nov-2025 2026-03-14T04:04:44.689Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/eanm-policy-bulletin-nov-2025 2026-03-14T04:04:44.689Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/new-eanm-overarching-narrative-feb-2026 2026-03-14T04:04:44.689Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/critical-medicines-act-moves-forward-dec-2025 2026-03-14T04:04:44.689Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/volumetric-changes-and-acute-toxicity-with-68ga-prostate-specific-membrane-antigen-versus-18f-fluciclovine-positron-emission-tomographycomputer-tomography-guided-postprostatectomy-radiation-final-analysis-of-a-randomized-trial 2026-03-13T17:34:35.627Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/18-f-psma-1007-and-18-f-fdg-petct-findings-of-pulmonary-tuberculosis-mimicking-malignancy 2026-03-13T16:04:34.414Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/trajectory-timelines-and-treatment-efficacy-of-177lu-psma-617-radioligand-therapy-for-metastatic-castration-resistant-prostate-cancer-real-world-data-from-50-consecutive-cases-treated-in-a-single-canadian-center 2026-02-19T05:36:26.132Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/release-of-the-2026-european-nuclear-medicine-guide-jan-2026 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/pulmonary-eosinophilia-mimicking-metastatic-lung-lesions-on-fdg-pet-ct 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/new-method-for-triggering-and-imaging-seizures-can-help-guide-epilepsy-surgery 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/use-of-benzo-sedatives-like-valium-xanax-won-t-raise-dementia-risk-study 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/standardized-criteria-for-amino-acid-pet-imaging-could-improve-diagnosis-and-treatment-of-brain-metastases 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/oleanolic-acid-from-grapes-may-increase-chemotherapy-effectiveness 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/outlining-the-future-of-theranostics-in-neurooncology 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/radioiodine-therapy-found-to-improve-relative-survival-rates-of-differentiated-thyroid-cancer-patients 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/researchers-say-specialist-scanning-needed-to-help-endometriosis-patients 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/novel-imaging-strategy-detects-multiple-sub-types-of-triple-negative-breast-cancer 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/high-68ga-fapi-04-and-low-18f-fdg-uptake-in-a-patient-with-hepatic-epithelioid-hemangioendothelioma 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/journal-of-nuclear-medicine-technology-supplement-highlights-advances-in-theranostics-and-opportunities-for-growth 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/new-pet-imaging-method-simplifies-coronary-artery-disease-detection 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/pet-imaging-of-inflammation-predicts-recovery-guides-therapy-after-heart-attack 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/new-combination-therapy-found-safe-and-feasible-for-neuroendocrine-tumor-patients 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/intense-68ga-fapi-04-uptake-in-a-rare-case-of-multifocal-abdominal-wall-endometriosis 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/dual-targeting-radiopharmaceutical-therapy-safe-and-effective-across-multiple-cancers 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/new-therapy-delays-progression-of-recurrent-prostate-cancer 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/head-to-head-comparison-of-18f-mfbg-and-68ga-ga-dota-tate-petct-in-suspected-recurrentrefractory-neuroblastoma-prospective-single-center-analysis 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/ultra-sensitive-detection-of-bone-metastasis-from-accessory-breast-cancer-using-her2-petct-a-case-report 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/beyond-parkinsonism-18f-fdopa-brain-petmri-for-detection-of-high-grade-glioma 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/18f-fluoroestradiol-uptake-in-benign-nodular-sclerosing-adenosis-of-the-breast 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/prognostic-value-of-fdg-petct-parameters-in-patients-with-advanced-biliary-tract-cancer-receiving-gemcitabine-cisplatin-and-nab-paclitaxel 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/novel-combined-pet-imaging-approach-personalizes-treatment-for-head-and-neck-cancer 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/rare-case-of-penile-metastasis-in-prostate-carcinoma-following-radical-prostatectomy-on-68ga-psma-petct 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/post-treatment-imaging-improves-safety-and-personalizes-care-in-radiopharmaceutical-therapy 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/rapid-growth-of-radiopharmaceutical-therapy-highlights-need-for-expertise 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/optimizing-intrahepatic-cholangiocarcinoma-staging 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/new-pet-imaging-approach-provides-precise-mapping-of-nasopharyngeal-cancer-biomarker 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/prostate-cancer-therapies-ai-based-image-analysis-detects-early-organ-damage 2026-02-04T08:12:04.464Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/new-criteria-developed-for-appropriate-use-of-cognitive-impairment-imaging-tools 2025-01-17T18:00:29.000Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/petct-provides-superior-lesion-detection-for-head-and-neck-paragangliomas-compared-to-gold-standard-mri 2024-06-10T18:34:02.000Z weekly 0.8 https://conmedru-nuclear-web-199d.twc1.net/news/new-study-highlights-potential-of-covalent-radioligands-in-cancer-treatment 2024-06-04T14:53:03.000Z weekly 0.8